Original paper
Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis
Abstract
Objectives. A probabilistic model was developed to determine the cost-effectiveness of three biologics, etanercept, infliximab and adalimumab, compared with palliative care for the treatment of active and progressive PsA in patients who have an inadequate response to standard treatment (including DMARDs). Methods. A previous model was revised to evaluate the impact of biologics on both skin and joint disease and to include new evidence from the...
Paper Details
Title
Modelling the cost-effectiveness of biologic treatments for psoriatic arthritis
Published Date
Aug 21, 2011
Journal
Volume
50
Issue
suppl 4
Pages
iv39 - iv47
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History